bbi-biotech offers products for up- and downstream processes in the production of API.

First products are sampling systems for sterile processes.

bbi – sampling systems are interfacing bioreactors with state-of-the-art analytics.

So these systems are an important brick for the PAT-initiative of the FDA.

bbi-biotech realises in their characteristics unique technical solutions.

bbi – bioreactors will

• overcome limitations of todays disposable bioreactors
• cut down investment and operative costs